| Independent Reports (Showing 1 to 10 of 16) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 24-May-13 | New Constructs, LLC | N/A | SVNT: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | View Abstract |
| 23-May-13 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for SVNT | 11 | $126.50 | View Abstract |
| 20-May-13 | Pechala's Reports | Lubomir Pechala | SAVIENT PHARMACEUTICALS INC (SVNT) - REPORT FOR ACTIVE TRADERS | 1 | $25 | View Abstract |
| 18-May-13 | Pechala's Reports | Frantisek Pechala | SAVIENT PHARMACEUTICALS INC (SVNT) 12-months forecast | 1 | $15 | View Abstract |
| 17-May-13 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Savient Pharmaceuticals Inc. | 41 | $471.50 | View Abstract |
| 17-May-13 | Ford Investor Services, Inc. | N/A | Industry Value Graph: AEZS , MDCO , QLTI , REGN , SVNT , TECH -- DRUGS | 3 | $34.50 | View Abstract |
| 17-May-13 | Ford Investor Services, Inc. | N/A | Value Graph: SAVIENT PHARM -- SVNT | 1 | $11.50 | View Abstract |
| 16-May-13 | S&P Capital IQ Quantitative Report | N/A | Savient Pharmaceuticals | 6 | $69 | View Abstract |
| 15-May-13 | Zacks Investment Research Inc. | N/A | SAVIENT PHARM (SVNT) Zacks Company Snapshot | 1 | $11.50 | View Abstract |
| 12-May-13 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: SAVIENT PHARMACEUTICALS INC | 5 | $10 | View Abstract |